Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
$24.79
-0.2%
$25.27
$20.52
$38.50
N/AN/A15,226 shs8,188 shs
AFJKR
Aimei Health Technology
$0.28
+3.7%
$0.25
$0.10
$0.39
N/AN/A51,091 shs1,600 shs
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
$19.93
+0.2%
$19.34
$16.65
$20.37
N/AN/A159,713 shs121,265 shs
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
$26.55
+0.1%
$26.27
$24.90
$27.70
N/AN/A3,578 shs936 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
-0.16%-0.04%-2.84%-1.20%-2.59%
AFJKR
Aimei Health Technology
0.00%+3.70%+27.27%-22.22%+21.74%
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
+0.28%-0.50%+3.42%+7.79%+8.67%
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
+0.02%+0.97%+1.51%-1.10%-0.86%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
N/AN/AN/AN/AN/AN/AN/AN/A
AFJKR
Aimei Health Technology
N/AN/AN/AN/AN/AN/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
0.00
N/AN/AN/A
AFJKR
Aimei Health Technology
0.00
N/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
0.00
N/AN/AN/A
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
$134.58MN/AN/AN/AN/AN/A
AFJKR
Aimei Health Technology
N/AN/AN/AN/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
$48.76MN/AN/AN/AN/AN/A
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
N/AN/A0.00N/AN/AN/AN/A8/11/2025 (Estimated)
AFJKR
Aimei Health Technology
N/AN/A0.00N/AN/AN/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
N/AN/A0.00N/AN/AN/AN/AN/A
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
N/AN/AN/AN/AN/A
AFJKR
Aimei Health Technology
N/AN/AN/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
$2.4212.14%N/AN/AN/A
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
N/AN/AN/AN/AN/A

Latest HROWM, ABLLL, ASGI, and AFJKR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/11/2025
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
monthly$0.2112.7%6/23/20256/23/20256/30/2025
5/13/2025
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
monthly$0.2012.6%5/22/20255/22/20255/30/2025
5/5/2025
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
quarterly$0.61729.5%5/13/20255/13/20255/15/2025
4/10/2025
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
monthly$0.2013%4/23/20254/23/20254/30/2025
4/15/2025
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
Quarterly$0.742211.1%4/15/20254/15/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
ABLLL
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028
N/AN/AN/AN/A
AFJKR
Aimei Health Technology
N/AN/AN/AN/A
Abrdn Global Infrastructure Income Fund stock logo
ASGI
Abrdn Global Infrastructure Income Fund
N/AN/AN/ANot Optionable
HROWM
Harrow Health, Inc. 11.875% Senior Notes due 2027
125N/AN/ANot Optionable

Recent News About These Companies

Learn to Evaluate (HROWM) using the Charts
When the Price of (HROWM) Talks, People Listen
(HROWM) Trading Signals
Trading (HROWM) With Integrated Risk Controls
Harrow Inc. 11.875% Sr. Notes due 2027
How To Trade (HROWM)
Long Term Trading Analysis for (HROWM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 NASDAQ:ABLLL

$24.79 -0.04 (-0.16%)
Closing price 06/26/2025 03:59 PM Eastern
Extended Trading
$24.82 +0.03 (+0.12%)
As of 06/26/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aimei Health Technology NASDAQ:AFJKR

$0.28 +0.01 (+3.70%)
As of 06/23/2025

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Abrdn Global Infrastructure Income Fund stock logo

Abrdn Global Infrastructure Income Fund NYSE:ASGI

$19.93 +0.03 (+0.15%)
Closing price 06/26/2025 03:58 PM Eastern
Extended Trading
$19.77 -0.16 (-0.80%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aberdeen Standard Global Infrastructure Income Fund seeks to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society. The Fund seeks to achieve its investment objective by investing in a portfolio of income-producing public and private infrastructure equity investments from around the world.

Harrow Health, Inc. 11.875% Senior Notes due 2027 NASDAQ:HROWM

$26.56 +0.04 (+0.15%)
As of 06/26/2025 03:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas